DJIA 17,096.19 9.56 0.06%
NASDAQ 4,472.01 -1.69 -0.04%
S&P 500 1,987.20 0.19 0.01%
market minute promo

Celgene (NASDAQ: CELG)

85.00 -4.12 (-4.62%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CELG $85.18 -4.42%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $87.26
Previous Close $89.12
Daily Range $84.25 - $87.76
52-Week Range $65.76 - $90.50
Market Cap $68.1B
P/E Ratio 56.76
Dividend (Yield) $0.00 (0.0%)
Volume 2,858,621
Average Daily Volume 4,917,294
Current FY EPS $3.18

Sector

Healthcare

Industry

Drugs

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website: http://www.celgene.com/

News & Commentary Rss Feed

Can Celgene Deliver in 2014?

Celgene (NASDAQ: CELG) had a strong 2013, but 2014 is not quite going to plan. Can it turn things around?

Celgene (CELG) Stock Falls After Mixed Second-Quarter Earnings

Q2 2014 Celgene Corp Earnings Conference Call (Webcast)

Sector Update: Health-Care Shares Higher Pre-Market

Sector Update: Health Care

Jim Cramer's Top Stock Picks: PEP CELG GILD REGN BIIB CMG

IPO Preview: Atara Biotherapeutics

Will Generics Eat Into Eli Lilly's (LLY) Q2 Earnings? - Analyst Blog

Jim Cramer's 'Mad Money' Recap: Unconventional Wisdom

Biogen's Q2 Earnings Surpass Expectations, Tecfidera Shines - Analyst Blog

Pre-Market Earnings Report for July 24, 2014 : MMM, UNP, BMY, LLY, CELG, F, CAT, GM, PCP, ALXN, POT

Pre-Market Earnings Report for July 24, 2014 : MMM, UNP, BMY, LLY, CELG, F, CAT, GM, PCP, ALXN, POT, RTN

See More CELG News...

CELG's Top Competitors

CELG $85.00 (-4.62%)
Current stock: CELG
AMGN $121.63 (-0.31%)
Current stock: AMGN
BIIB $337.34 (-0.08%)
Current stock: BIIB
GILD $91.03 (0.76%)
Current stock: GILD